心脏电气生物标志物对冠状动脉阻塞的反应的变化:一个实验观测
Sudipta Chattopadhyay1,2, Felicia Adjei3, Attila Kardos3,4
1Department of Cardiology, Bedford Hospital, Bedfordshire Hospitals NHS Foundation Trust, Kempston Road, Bedford, MK42 9DJ, UK. Sudipta.Chattopadhyay@nhs.net.
心脏电气生物标志物 (CEB) 在冠状动脉封闭期间增加,表明缺血. 在高血压期间的CEB准确地预测了分数流量储备,这表明CEB可以识别显著的冠状动脉疾病.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 缺血症研究 缺血症研究
背景情况:
- 心脏电气生物标志物 (CEB) 表示肌细胞极性变化由于缺血.
- 建议CEB在诊断急性冠状动脉综合征中的实用性,但其对冠状动脉封闭的反应尚未得到证实.
- 了解CEB在冠状动脉干预期间和之后的行为对于其临床应用至关重要.
研究的目的:
- 研究冠状动脉封闭对心脏电气生物标志物 (CEB) 的影响.
- 为了确定CEB是否可以预测断片流量储备 (FFR) 值,表明缺血症.
- 评估CEB在穿皮冠状动脉干预期间和之后的动态变化.
主要方法:
- 在测量CEB之前,在最大腺激素高血压 (CEBhyp) 期间,在气球膨胀 (CEBmax) 期间,以及穿皮冠状动脉干预后1,2,3小时.
- 在75名接受支架的患者 (除以FFR<0.8或≥0.8) 和49名对照患者中进行了测量.
- CEB的晚期恢复 (LR) 被定义为PCI后3小时的CEB大于基线CEB的中位数.
主要成果:
- 冠状动脉封闭显著增加了CEB,CEBmax和早期的术后值高于基线.
- 与FFR≥0.8.8的患者相比,FFR<0.8的患者的CEBhyp显著更高.
- CEBhyp准确预测了FFR<0.8 (AUC0.75,p=0.017),而CEBmax预测了CEB晚期恢复.
结论:
- 冠状动脉堵塞增加了CEB,它保留了缺血事件的"记忆".
- 在高血症 (CEBhyp) 期间测量的CEB在缺血性条件下特别升高 (FFR<0.8).
- CEBhyp显示出作为一种非侵入性方法的潜力,用于识别显著的冠状动脉疾病并指导干预决策.
更多相关视频
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Mechanism of Cardiac Arrhythmias
Pathophysiology of Cardiac Performance
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
